Preliminary ARS data show a decreasing trend in mecillinam resistance for E. coli isolates in urine samples from 7.9% (n = 196,028 tested isolates) in 2019 to 4.8% (n = 333,301) in 2022.
← all excerpts
Letter to the editor: Antimicrobial resistance data and treatment guidelines - challenges in the context of urine samples and mecillinam testing.
1
—
—